ICU Medical Non-GAAP EPS of $2.03 beats by $0.60, revenue of $537M beats by $25.52M

* ICU Medical press release [https://seekingalpha.com/pr/20297932-icu-medical-announces-third-quarter-2025-results-and-updates-its-fiscal-year-2025-guidance] (ICUI [https://seekingalpha.com/symbol/ICUI]): Q3 Non-GAAP EPS of $2.03 beats by $0.60.
* Revenue of $537M (-8.8% Y/Y) beats by $25.52M.
* For Fiscal Year 2025 the Company is updating its estimates of GAAP net loss from a range of $(43) million to $(35) million to a range of $(8) million to $0 million and GAAP diluted loss per share from a range of $(1.68) to $(1.38) to a range of $(0.30) to $0.00. The Company is updating the estimate of the range of its full year 2025 guidance of adjusted EBITDA from a range of $380 million to $390 million to a range of $395 million to $405 million and diluted earnings per share from a range of $6.85 to $7.15 to a range of $7.35 to $7.65.

MORE ON ICU MEDICAL

* ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4821530-icu-medical-inc-icui-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference]
* ICU Medical, Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4811863-icu-medical-inc-2025-q2-results-earnings-call-presentation]
* ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4811862-icu-medical-inc-icui-q2-2025-earnings-call-transcript]
* ICU Medical Q3 2025 Earnings Preview [https://seekingalpha.com/news/4516064-icu-medical-q3-2025-earnings-preview]
* ICU Medical wins bullish view at Piper Sandler on upcoming product cycle wave [https://seekingalpha.com/news/4486199-icu-medical-stock-wins-bullish-view-piper-sandler]